Expression of the Von Hippel—Lindau Disease Tumour Suppressor Gene during Human Embryogenesis

Author： Richards Frances M. Schofield Paul N. Fleming Stewart Maher Eamonn R.

ISSN： 1460-2083

Source： Human Molecular Genetics, Vol.5, Iss.5, 1996-01, pp. : 639-644

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genotype–phenotype correlation in von Hippel-Lindau syndrome

By A.Friedrich C.

Human Molecular Genetics, Vol. 10, Iss. 7, 2001-04 ,pp. : 763-767

Oxford University Press

Access to resources Recommend Favorite

von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF

By Hoffman M.A.

Human Molecular Genetics, Vol. 10, Iss. 10, 2001-05 ,pp. : 1019-1027

Oxford University Press

Access to resources Recommend Favorite

Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease

By Clifford S.C.

Human Molecular Genetics, Vol. 10, Iss. 10, 2001-05 ,pp. : 1029-1038

Oxford University Press

Access to resources Recommend Favorite

Expression of the PTEN tumour suppressor protein during human development

By Gimm Oliver

Human Molecular Genetics, Vol. 9, Iss. 11, 2000-07 ,pp. : 1633-1639

Oxford University Press

Access to resources Recommend Favorite

Expression of the von Hippel–Lindau-binding protein-1 ( Vbp1 ) in fetal and adult mouse tissues

By Hemberger M.

Human Molecular Genetics, Vol. 8, Iss. 2, 1999-02 ,pp. : 229-236

Oxford University Press

Access to resources Recommend Favorite